X-Cor Therapeutics Inc
X-Cor Therapeutics Inc, based in Baltimore, is pioneering the development of the first commercially available extracorporeal CO2 removal device, specifically designed for patients with hypercarbic respiratory failure. By utilizing ultra-low-blood flow technology, their innovative solution offers a more accessible, affordable, and effective treatment option for individuals suffering from chronic respiratory conditions and acute lung failure.
The company's core technology features a patent-pending hybrid cartridge that enables the removal of excess CO2 from the blood with minimal invasiveness, differing from traditional high-flow systems. Led by a team of experienced professionals from various medical and engineering backgrounds, X-Cor is committed to improving patient outcomes and enhancing the overall quality of life for millions affected by respiratory difficulties.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
